News
Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA
By Stephanie Brown HealthDay ReporterTUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Tuesday that Moderna has agreed to a true ...
For children, yes, the CDC’s “shared decision-making” guidance preserves the status quo in which Medicaid and U.S.
Federal health officials issued new guidance last week on who should have the COVID-19 vaccine, and it no longer includes healthy children and healthy pregnant women.
The Trump administration has moved to end funding for a broad swath of HIV vaccine research, saying current approaches are ...
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
Federal health officials have changed the game for COVID vaccine access. Pregnant moms and others who rely on them to protect a high-risk family member are scared.
The US Centers for Disease Control and Prevention has updated its immunization schedule for children, days after US Health ...
Cuts in NIH grants and the threat of more are discouraging investment and may drive trials out of the United States.
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback